The Boardroom

The Alzheimer's Association Delaware Valley Chapter

, Philadelphia, has elected

John S. Smith

and

Cate Weaver

to its board. Smith is business-development manager for Radnor-based GTM Global Tax Management. Weaver is CEO of CSG Global.

Rita R. Chaiken

has been named president of the

Academy of Doctors of Audiology.

She is an adjunct faculty member at Salus University's George S. Osborne College of Audiology.

Community Legal Services and Philadelphia Legal Assistance have elected three new members to their overlapping board of directors: William Cobb, a former CLS client and founder of Redeemed; Tom Duffy, founder of Duffy + Partners and the Duffy Fellowship; and Lauren P. McKenna, a partner at Fox Rothschild L.L.P. Founded in 1966, CLS is Philadelphia's oldest and largest nonprofit law firm devoted to ensuring the access to justice for low-income people. PLA has been Philadelphia's federally funded civil legal services provider since 1996.

Stradley Ronon partner E. Carolan Berkley has been appointed by the Secretary of the Commonwealth to the Pennsylvania Department of State Corporation Bureau. The bureau maintains the records repository of more than 2.6 million companies that do business in the commonwealth and serves as the centralized filing office for Uniform Commercial Code financing statements

Egalet Corp., a Wayne-based specialty pharmaceutical company focused on developing, manufacturing, and commercializing innovative treatments for pain and other conditions, has appointed the following industry veterans to its newly formed scientific advisory board: Vincent Lee, a research professor and former director of the School of Pharmacy at the Chinese University of Hong Kong and former chairman of the department of pharmaceutical sciences at the School of Pharmacy at the University of Southern California; Jacques-Pierre Moreau, former founder and president of Biomeasure Inc. and chief scientific officer and executive vice president of Ipsen SA (France); Nicholas Nicolaides, president, CEO and cofounder of Morphotek; Kenneth Shea, professor of chemistry at the School of Physical Science at the University of California, Irvine; Giovanni Traverso, instructor in medicine at Harvard Medical School, a gastroenterologist at the Massachusetts General Hospital and a research affiliate at the Massachusetts Institute of Technology; and Jeffrey Wilkins, chief medical officer of Lycera.

Spark Therapeutics Inc., a Philadelphia developing gene-therapy company initially focusing on therapies to treat rare diseases, has named Lota Zoth to its board. Zoth has served in senior financial roles in a variety of commercial-stage companies over a 30-year career, including serving as chief financial officer for MedImmune before its acquisition by AstraZeneca in 2007, and leadership experience at PSINet, Sodexho, Marriott International, and PepsiCo Inc. - Mike Zebe